Search our Database of Scientific Publications and Authors

I’m looking for a
    Use of Phototherapy in Children.
    Pediatr Dermatol 2017 Mar 30;34(2):150-155. Epub 2017 Jan 30.
    Department of Dermatology, Alder Hey Children's Hospital, Liverpool, UK.
    Background: Phototherapy is a well-recognized treatment in adults and children. Previous articles have reported success in treating recalcitrant skin disorders such as atopic dermatitis (AD), psoriasis, pityriasis lichenoides chronica, and vitiligo in children.

    Methods: This was a retrospective review over an 18-month period from June 2012 to December 2013 of all children receiving phototherapy in a tertiary pediatric dermatology center.

    Results: Seventy-five patients 3 to 17 years of age (mean 10.6 years; 35 male, 40 female) were included. Forty-eight (64%) patients had AD and 21 (28%) had psoriasis. Seventy received narrowband ultraviolet B (NBUVB) treatment and five received hand and foot psoralen and ultraviolet A (PUVA) treatment. All patients with AD were treated with NBUVB and four (8.3%) were also treated with hand PUVA. After phototherapy, 76% had documented clear to almost clear skin. At the 12-month follow-up, 52% of the patients with AD remained clear. All 21 patients with psoriasis underwent NBUVB phototherapy. The clearance rate after phototherapy was 86%. At the 12-month follow-up, 43% of the patients with psoriasis remained clear.

    Conclusion: Phototherapy can reduce disease burden in individuals with severe AD and psoriasis and should be considered as a second-line therapy if standard topical regimens are unsuccessful.

    Similar Publications

    Phototherapy in childhood.
    Pediatr Dermatol 2008 Nov-Dec;25(6):599-605
    Department of Dermatology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
    Background: Little data exist about the efficacy of phototherapy in childhood dermatoses.

    Objective: To report our experience with pediatric patients treated with phototherapy.

    Methods: The study included children Read More
    Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
    J Am Acad Dermatol 2003 Sep;49(3):473-6
    Division of Dermatology, Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
    Background: Narrowband ultraviolet B (NBUVB) has recently been reported to be effective therapy for vitiligo. However, reports on its efficacy in recalcitrant vitiligo are lacking.

    Objective: Our objective was to assess the efficacy of NBUVB in patients with vitiligo who did not respond to either topical therapy or oral psoralen plus ultraviolet A (PUVA). Read More
    Phototherapy in pediatric patients.
    Pediatr Dermatol 2003 Jan-Feb;20(1):71-7
    Department of Dermatology and Venerology, Zagreb University Hospital Center, Zagreb, Croatia.
    The treatment of children with psoriasis, atopic dermatitis (AD), pityriasis lichenoides, and scleroderma poses a therapeutic problem because all therapeutic options are associated with numerous side effects. Therefore ultraviolet A and B (UVA and UVB) phototherapy is presented as a possible alternative to some of these therapies, primarily topical and systemic corticosteroids, in children. Our results in treating children with phototherapy and psoralen plus UVA (PUVA) bath phototherapy over the past 5 years are reported. Read More
    Phototherapy in pediatric patients: choosing the appropriate treatment option.
    Semin Cutan Med Surg 2010 Jun;29(2):115-20
    University of California, School of Medicine, Irvine, CA, USA.
    Phototherapeutic modalities, including narrowband-UVB, broadband-UVB, PUVA photochemotherapy, and excimer laser therapy are valuable tools that can be used for photoresponsive dermatoses in children. As a systematically safer alternative compared with internal agents, including the prebiologic and biological therapies, phototherapy should be considered a possible treatment option for children with diseases including psoriasis, atopic dermatitis, pityriasis lichenoides chronica, and vitiligo. Read More